-
propan-2-yl (2S)-2-[(2S)-2-{[(2S,3R)-2-{[(2R)-2-amino-3-sulfanylpropyl]amino}-3-methylpentyl]oxy}-3-phenylpropanamido]-4-methanesulfonylbutanoate
-
ChemBase ID:
172464
-
Molecular Formular:
C26H45N3O6S2
-
Molecular Mass:
559.782
-
Monoisotopic Mass:
559.27497818
-
SMILES and InChIs
SMILES:
N[C@H](CN[C@H](CO[C@H](C(=O)N[C@H](C(=O)OC(C)C)CCS(=O)(=O)C)Cc1ccccc1)[C@H](C)CC)CS
Canonical SMILES:
CC[C@H]([C@H](NC[C@H](CS)N)CO[C@H](C(=O)N[C@H](C(=O)OC(C)C)CCS(=O)(=O)C)Cc1ccccc1)C
InChI:
InChI=1S/C26H45N3O6S2/c1-6-19(4)23(28-15-21(27)17-36)16-34-24(14-20-10-8-7-9-11-20)25(30)29-22(12-13-37(5,32)33)26(31)35-18(2)3/h7-11,18-19,21-24,28,36H,6,12-17,27H2,1-5H3,(H,29,30)/t19-,21-,22+,23-,24+/m1/s1
InChIKey:
PGOKBMWPBDRDGN-ZXGKGEBGSA-N
-
Cite this record
CBID:172464 http://www.chembase.cn/molecule-172464.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
propan-2-yl (2S)-2-[(2S)-2-{[(2S,3R)-2-{[(2R)-2-amino-3-sulfanylpropyl]amino}-3-methylpentyl]oxy}-3-phenylpropanamido]-4-methanesulfonylbutanoate
|
|
|
IUPAC Traditional name
|
isopropyl (2S)-2-[(2S)-2-{[(2S,3R)-2-{[(2R)-2-amino-3-sulfanylpropyl]amino}-3-methylpentyl]oxy}-3-phenylpropanamido]-4-methanesulfonylbutanoate
|
|
|
Synonyms
|
(2S)-[(2S)-[(2R)-Amino-3-mercapto]-propylamino-(3S)-methyl]pentyloxy-3-phenylpropionyl-methionine Sulfone Isopropyl Ester Bis Hydrchloride
|
L-744832
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
10.252534
|
H Acceptors
|
7
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-2.9976766
|
LogD (pH = 7.4)
|
-0.5411499
|
Log P
|
1.378605
|
Molar Refractivity
|
148.8764 cm3
|
Polarizability
|
60.129036 Å3
|
Polar Surface Area
|
136.82 Å2
|
Rotatable Bonds
|
19
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
L744832
|
Ras farnesyltransferase inhibitor. Induces tumor regression in transgenic mice with multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Induces p21 expressoin and arrests cells at G1. Causes enhanced mitotic |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Barrington, R.E., et al.: Mol. Cell. Biol., 18, 85 (1998, Sepp-Lorenzo, L. and Rosen, N.: J. Biol. Chem., 273, 20243 (1998)
- • Moasser, M.M., et al.: Proc. Natl. Acad. Sci. USA, 95, 1369 (1998)
- • Law, B.K., et al.: J. Biol. Chem., 275, 10796 (1998)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent